Spearman correlation test showed a significant positive correlation between right ventricular dysfunction or elevated cardiac troponin level and massive PE (r=0.54, p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Aim: To investigate whether there is a relationship between both massive and sub-massive pulmonaryembolism (PE) and eosinophil counts in order to evaluate it as a predictor factor.Methods: This retrospective study included 108 patients (64 sub-massive and 44 massive) who received bothtomographic and clinical diagnoses of pulmonary embolism, and 75 subjects served as controls.
📊
Temel Bulgular & Veri:The eosinophil counts increased significantly one weekafter the treatment when compared to those at the presentation with PE (0.112 (0.003-0.853) vs. (0.144 (0.011- 0.914), p=0.01).
💡
Sonuç & Katkı:Spearman correlation test showed a significant positive correlation between right ventricular dysfunction or elevated cardiac troponin level and massive PE (r=0.54, p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Aim: To investigate whether there is a relationship between both massive and sub-massive pulmonaryembolism (PE) and eosinophil counts in order to evaluate it as a predictor factor.Methods: This retrospective study included 108 patients (64 sub-massive and 44 massive) who received bothtomographic and clinical diagnoses of pulmonary embolism, and 75 subjects served as controls. Hemogramparameters were compared between patients with massive and sub-massive pulmonary embolism and those ofcontrol groups. Results: In terms of white blood cell and eosinophil counts, the lowest value was evident in the massive PEgroup whereas the control group had the highest value. The eosinophil counts increased significantly one weekafter the treatment when compared to those at the presentation with PE (0.112 (0.003-0.853) vs. (0.144 (0.011- 0.914), p=0.01). Spearman correlation test showed a significant positive correlation between right ventricular dysfunction or elevated cardiac troponin level and massive PE (r=0.54, p
🔖
Bu Makaleye Atıf Yap
SİNCER, İ., MANSIROĞLU, A. K., GÜNEŞ, Y., COŞGUN, M. (2022). Comparison of eosinophil counts in patients with acute pulmonary embolism: Could itbe a predictor factor?. Experimental Biomedical Research, Cilt: 4 - Sayı: 4, 283–290. https://ajindex.com/articles/512600
Li D, Xu L, Lin D, et al. Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome. Respir Med Case Rep. 2018
Becattini C, Agnelli G. Aspirin for prevention and treatment of venous thromboembolism. Blood Rev. 2014
28(3):103-8. [3]van der Hulle T, Tan M, den Exter PL, et al. Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism. Haematologica. 2015
100(2):188-93. [4]Prentice RL, Szatrowski TP, Fujikura T, et al. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol. 1982
116(3):496-509. [5]Jiang P, Wang DZ, Ren YL, et al. Significance of eosinophil accumulation in the thrombus and decrease in peripheral blood in patients with acute coronary syndrome. Coron Artery Dis. 2015
26(2):101-6. [6]Sakai T, Inoue S, Matsuyama TA, et al. Eosinophils may be involved in thrombus growth in acute coronary syndrome. Int Heart J. 2009
50(3):267-77. [7]Rohrbach MS, Wheatley CL, Slifman NR, et al. Activation of platelets by eosinophil granule proteins. J Exp Med. 1990
172(4):1271-74. [8]Slungaard A, Vercellotti GM, Tran T, et al. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest. 1993
91(4):1721-30. [9]Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014
35(43):3033- 69, 3069a-3069k. [10]Reekers JA, Baarslag HJ, Koolen MG, et al. Mechanical thrombectomy for early treatment of massive pulmonary embolism. Cardiovasc Intervent Radiol. 2003
26(3):246-50. [11]Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007
44(2):62-69. [12]Tenekecioglu E, Yilmaz M, Bekler A, et al. Eosinophil count is related with coronary thrombus in non ST-elevated acute coronary syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015
159(2):266-71. [13]Mukai HY, Ninomiya H, Ohtani K, et al. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br J Haematol. 1995
90(4):892-99. [14]Moosbauer C, Morgenstern E, Cuvelier SL, et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood. 2007
109(3):995-1002. [15] Sharma SK, Kumar S, Seth T, et al. Eosinophilia: Rare cause of arterial thrombosis and cardioembolic stroke in chil